The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dose-painted intensity-modulated radiation therapy (DP-IMRT) for anal cancer: No differences in treatment toxicity and early outcomes between human immunodeficiency virus (HIV) positive and negative patients.
Paul B. Romesser
No relevant relationships to disclose
Joseph D. Mancias
No relevant relationships to disclose
Muhammad M. Qureshi
No relevant relationships to disclose
Kevan L. Hartshorn
No relevant relationships to disclose
John D. Willins
No relevant relationships to disclose
Theodore S. Hong
No relevant relationships to disclose
Lisa A. Kachnic
No relevant relationships to disclose